← Leaderboards
Carlos Tristan
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Induced Pluripotent Stem Cell”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$77,143,245
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$72,554,837
- Joseph C Wu · Stanford University$63,140,589
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$50,800,152
- Li-Huei Tsai · Massachusetts Institute Of Technology$37,797,465
Research focus
Induced Pluripotent Stem CellNational Center For Advancing Translational SciencesAfferent NeuronsNociceptorsCollaborationsCellsPeripheral Nervous System DiseasesPainPeripheralDifferentiation ProtocolProtocols DocumentationGeneticNeurogliaStem CellsNeuronsElectrophysiology (Science)ManuscriptsTranscriptomicsCell TypeChemotherapy-Induced Peripheral NeuropathyPublishingDisease ModelDiabeticMultiple Omics
Grant awards (18)
Functional consequences of putative analgesic receptor activation in human DRG neuronal cultures from healthy donors$1,600,421
ZIA · FY2025 · TR · contact PI
SMCHD1 and hypothalamic neurogenesis$1,600,421
ZIA · FY2025 · TR · contact PI
Modeling Huntingtons disease in iPSC-derived astrocytes$1,600,421
ZIA · FY2025 · TR · contact PI
Bioengineering of propioceptor and intrafusal muscle composite tissue$640,169
ZIA · FY2025 · TR · contact PI
Evaluation of PEGylated oxidized activated charcoal nanoparticles therapeutic mechanisms in Friedreichs ataxia models$512,135
ZIA · FY2025 · TR · contact PI
Effect of organic chalcones on human cell lines and hPSC-derived cell types$320,084
ZIA · FY2025 · TR · contact PI
Optimization of Long-lasting Analgesia via Targeted Epigenetic Repression (LATER) for human use$92,231
ZIA · FY2025 · TR · contact PI
Characterization of human induced nociceptors produced by a novel iPSC differentiation protocol for disease modeling$92,231
ZIA · FY2025 · TR · contact PI
Multi-omic analysis of diabetic neuropathy in iPSC derived sensory neurons$92,231
ZIA · FY2025 · TR · contact PI
Studies of Chemotherapy Induced Peripheral Neuropathy (CIPN) in iPSC-derived$92,231
ZIA · FY2025 · TR · contact PI
Developing GPR37 activators as non-opioid pain therapeutics$64,017
ZIA · FY2025 · TR · contact PI
A Multi-organoid, Multi-modality AI Model for Heterogeneity and Precision Medicine in Type 2 Diabetes (MOMENT)$64,017
ZIA · FY2025 · TR · contact PI
Stem Cell Translation Laboratory (SCTL)$6,511,091
ZIA · FY2024 · TR · contact PI
Studies of Chemotherapy Induced Peripheral Neuropathy (CIPN) in iPSC-derived$75,761
ZIA · FY2024 · TR · contact PI
Multi-omic analysis of diabetic neuropathy in iPSC derived sensory neurons$75,760
ZIA · FY2024 · TR · contact PI
Characterization of human induced nociceptors produced by a novel iPSC differentiation protocol for disease modeling$75,760
ZIA · FY2024 · TR · contact PI
Optimization of Long-lasting Analgesia via Targeted Epigenetic Repression (LATER) for human use$75,760
ZIA · FY2024 · TR · contact PI
Stem Cell Translation Laboratory (SCTL)$6,242,548
ZIA · FY2023 · TR · contact PI